334
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Platelet function in patients with chronic myeloid leukemia treated with asciminib

ORCID Icon, , , , &
Pages 3021-3023 | Received 19 May 2020, Accepted 30 Jun 2020, Published online: 12 Jul 2020
 

Disclosure statement

GN: The author reports no conflict of interest. ML: Speaker fees from Pfizer. SC: The author reports no conflict of interest. AI: The author reports no conflict of interest. JA: Research funding and honoraria from Pfizer, honoraria from BMS, research funding and honoraria from Ariad (Incyte), honoraria from Novartis, support and senior investigator for Imperial College NIHR Biomedical Research Center. DM: Honoraria from Pfizer, BMS, Ariad (Incyte) and Novartis. Support for Imperial College NIHR Biomedical Research Center.

Author contributions

GN: wrote the manuscript and performed data analysis. DM: designed and supervised the study, and reviewed the manuscript. ML, SC, AI, JA: reviewed the manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.